Skip to content
10-Q

Quarterly Report

Pyxis Oncology, Inc. PYXS

0000950170-25-108906

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 62.02M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.92M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.89M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$39.8M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$23.72M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $10.73M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $19.47M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $25.07M
Stockholders Equity Q2 2025 · Jun 30, 2025 $87.64M
Stockholders Equity Q2 2025 · Mar 31, 2025 $103.1M
Stockholders Equity Q2 2025 · Dec 31, 2024 $120.75M
Stockholders Equity Q2 2025 · Jun 30, 2024 $169.79M
Stockholders Equity Q2 2025 · Mar 31, 2024 $184.16M
Stockholders Equity Q2 2025 · Dec 31, 2023 $125.7M
Current Liabilities Q2 2025 · Jun 30, 2025 $17.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $17.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $35.57M
Total Liabilities Q2 2025 · Dec 31, 2024 $36.43M
Current Assets Q2 2025 · Jun 30, 2025 $99.96M
Current Assets Q2 2025 · Dec 31, 2024 $132.44M
Total Assets Q2 2025 · Jun 30, 2025 $123.22M
Total Assets Q2 2025 · Dec 31, 2024 $157.18M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.64
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.29
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 −$0.30
Eps Basic Q2 2025 · Jun 30, 2025 −$0.64
Eps Basic Q2 2025 · Jun 30, 2024 −$0.29
Eps Basic Q2 2025 · Jun 30, 2024 −$0.37
Sga Expense Q2 2025 · Jun 30, 2025 $5.44M
Sga Expense Q2 2025 · Jun 30, 2025 $11.31M
Sga Expense Q2 2025 · Jun 30, 2024 $6.08M
Sga Expense Q2 2025 · Jun 30, 2024 $14.33M
Rd Expense Q2 2025 · Jun 30, 2025 $17.13M
Rd Expense Q2 2025 · Jun 30, 2025 $34.18M
Rd Expense Q2 2025 · Jun 30, 2024 $13.95M
Rd Expense Q2 2025 · Jun 30, 2024 $26.98M
Net Income Q2 2025 · Jun 30, 2025 −$18.35M
Net Income Q2 2025 · Jun 30, 2025 −$39.51M
Net Income Q2 2025 · Mar 31, 2025 −$21.16M
Net Income Q2 2025 · Jun 30, 2024 −$17.3M
Net Income Q2 2025 · Jun 30, 2024 −$20.56M
Net Income Q2 2025 · Mar 31, 2024 −$3.26M
Operating Income Q2 2025 · Jun 30, 2025 −$19.75M
Operating Income Q2 2025 · Jun 30, 2025 −$42.66M
Operating Income Q2 2025 · Jun 30, 2024 −$20.03M
Operating Income Q2 2025 · Jun 30, 2024 −$25.64M
Revenue Q2 2025 · Jun 30, 2025 $2.82M
Revenue Q2 2025 · Jun 30, 2025 $2.82M
Revenue Q2 2025 · Jun 30, 2024 $16.15M
Capex Q2 2025 · Jun 30, 2024 $237K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $475K